Related Experiment Video
Updated: Jun 3, 2026
07:04
Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
[Gene doping--current possibilities, risks and means of prevention]
N Pleger1, K Vitzthum, N Schöffel
1Institut für Arbeitsmedizin, Charité-Universitätsmedizin Berlin, Zentrum für Human- und Gesundheitswissenschaften, Freie Universität & Humboldt-Universität zu Berlin.
Summary
Gene doping, the use of gene therapy for athletic enhancement, poses significant risks including immune reactions and cancer. Detection methods are still under development, but its use cannot be ruled out.
Area of Science:
- Sports Science
- Genetics
- Biotechnology
Context:
- Advances in gene therapy raise concerns about potential misuse in sports.
- The World Anti-Doping Agency (WADA) distinguishes gene doping from gene therapy.
- Gene doping involves manipulating gene expression using in vivo or ex vivo methods, often with viral vectors.
Purpose:
- To explore the scientific basis and implications of gene doping in sports.
- To identify key genes and pathways targeted for performance enhancement.
- To assess the current state of detection methods and potential risks.
Summary:
- Gene doping utilizes gene expression manipulation for athletic advantage, targeting genes like IGF-1, PPARδ, MSTN, and EPO.
- Animal studies demonstrate significant performance improvements, but human application carries risks such as severe immune reactions, mutagenesis, and cancer.
- Despite ongoing research into detection, practical control methods are lacking, though gene doping's past use is considered likely.
Impact:
- Highlights the urgent need for robust detection strategies and ethical guidelines in sports.
- Informs athletes, sports organizations, and researchers about the potential dangers and scientific underpinnings of gene doping.
- Underscores the dual-use nature of gene therapy technologies and the challenges in preventing their illicit application.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:49What is Genetic Engineering?
Overview
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...